Bernstein analyst Rebecca Liang maintained a Hold rating on BeiGene (ONC – Research Report) today and set a price target of $259.00. The ...

SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U ...

BeiGene (ONC) announced the U.S. FDA has approved Ttevimbra in combination with platinum-containing chemotherapy, for the first-line treatment of adults with unresectable or metastatic esophageal ...

Get Our Latest Research Report on ONC Beigene Trading Down 9.7 % The firm has a market cap of $24.03 billion, a PE ratio of -29.80, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. The ...

Beigene has a one year low of $126.97 and a one year high of $287.88. The firm has a market capitalization of $24.03 billion, a P/E ratio of -29.80, a P/E/G ratio of 7.73 and a beta of 0.63.

In this article, we are going to take a look at where BeiGene, Ltd. (NASDAQ:ONC) stands against other best immunology stocks to buy now. Immunology is a rapidly advancing field with significant ...

We raise our fair value estimate for no-moat BeiGene to HKD 149 per share from HKD 132, based on better-than-expected Brukinsa sales in the last quarter and a faster ramp-up going forward.

Business Wire India Total global revenues of $1.1 billion and $3.8 billion for the fourth quarter and full year, increases of 78% and 55%, respectively; narrowed GAAP operating loss and achieved full- ...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced financial results and corporate updates ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that ...